Abstract
To evaluate bronchial reactivity to methacholine in human immunodeficiency virus (HIV) infection, we submitted 25 HIV-seropositive subjects without full-blown AIDS and 25 HIV-seronegative subjects, all inmates in a drug rehabilitation center for previous intravenous drug abuse, to interview and to bronchial challenge with methacholine. Four (16 percent) HIV-seropositive and three (12 percent) HIV-seronegative subjects noted bronchospastic symptoms. Baseline FEV 1 and MEF50 percent were within the normal range in every patient. Bronchial hyperreactivity to methacholine (PD20FEV 1
Original language | English |
---|---|
Pages (from-to) | 796-799 |
Number of pages | 4 |
Journal | Chest |
Volume | 103 |
Issue number | 3 |
Publication status | Published - 1993 |
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine